title: Seroprevalence and national distribution of human toxoplasmosis in Mexico: analysis of the 2000 and 2006 National Health Surveys.
abstract: Global warming has had serious implications on dispersion of infectious diseases like toxoplasmosis. Since the frequency of Toxoplasma gondii largely depends on climatic conditions, we studied its prevalence by means of 3599 samples of the National Health Survey 2000 (NHS-2000) and 2916 of the National Health and Nutrition Survey 2006 (NHNS-2006) serum banks, obtained from 1-98 year old subjects of both genders and all states of Mexico. Anti-T.gondii IgG antibodies were determined by ELISA and confirmed by western blot. Crude, epidemiologically weighted and diagnosis-performance-adjusted prevalence values were calculated. Seroprevalence changes were compared between both surveys and among regions (north, center and coast). Also, correlations between changes in temperature or humidity and those in prevalence were measured. National crude prevalence was 60.1% and 62.6% for NHS-2000 and NHNS-2006, respectively. Weighted and adjusted values were 62.5% and 40.0% for NHS-2000, and 63.7 and 43.1% for NHNS-2006. Coastal states and children presented the largest increases between surveys, while the center of the country showed a decrease. An apparently higher prevalence of T. gondii infection was observed in both surveys compared to that performed in 1987, while a geographical re-distribution was found from 2000 to 2006, with a positive correlation between temperature and frequency deltas in 21 states where prevalence increased.
authors.affiliation: Laboratorio de Inmunología Experimental. Subdirección de Medicina Experimental. Instituto Nacional de Pediatría, SSA, México DF, C.P. 04530, México.
authors.forename: Heriberto
authors.initials: H
authors.lastname: Caballero-Ortega
authors.forename: Felipe Javier
authors.initials: FJ
authors.lastname: Uribe-Salas
authors.forename: Carlos J
authors.initials: CJ
authors.lastname: Conde-Glez
authors.forename: Carlos
authors.initials: C
authors.lastname: Cedillo-Pelaez
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Vargas-Villavicencio
authors.forename: Héctor
authors.initials: H
authors.lastname: Luna-Pastén
authors.forename: Irma
authors.initials: I
authors.lastname: Cañedo-Solares
authors.forename: Luz Belinda
authors.initials: LB
authors.lastname: Ortiz-Alegría
authors.forename: Dolores
authors.initials: D
authors.lastname: Correa
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000913:Antibodies, Protozoan / Q000097:blood*; D015153:Blotting, Western; D002648:Child; D002675:Child, Preschool; D057231:Climate Change; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006306:Health Surveys; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007223:Infant; D008297:Male; D008800:Mexico / Q000453:epidemiology; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D017678:Sex Distribution; D011795:Surveys and Questionnaires; D014122:Toxoplasma / Q000276:immunology / Q000302:isolation & purification*; D014123:Toxoplasmosis / Q000097:blood* / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D000913:Antibodies, Protozoan; D007074:Immunoglobulin G